Sale!

ABCB7 Gene Anemia Sideroblastic with Ataxia NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The ABCB7 Gene Anemia Sideroblastic with Ataxia NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the ABCB7 gene responsible for rare inherited disorders. This comprehensive test helps diagnose sideroblastic anemia combined with ataxia, providing crucial insights for proper medical management. Using next-generation sequencing technology, the test delivers highly accurate results within 3-4 weeks. The test costs $500 USD and requires a blood sample along with genetic counseling. Early detection through this test enables targeted treatment strategies and informed family planning decisions for individuals with symptoms or family history of these conditions.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

ABCB7 Gene Anemia Sideroblastic with Ataxia NGS Genetic DNA Test

Comprehensive Genetic Testing for Rare Blood and Neurological Disorders

The ABCB7 Gene Anemia Sideroblastic with Ataxia NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for rare inherited conditions. This advanced genetic analysis specifically targets the ABCB7 gene, which plays a critical role in iron metabolism and mitochondrial function. When mutations occur in this gene, they can lead to the development of sideroblastic anemia combined with neurological symptoms of ataxia, creating a complex medical condition that requires precise diagnosis for effective management.

What This Test Measures and Detects

Our NGS-based genetic test provides comprehensive analysis of the ABCB7 gene, identifying:

  • Point mutations and single nucleotide variants in the ABCB7 gene
  • Insertions and deletions affecting gene function
  • Splice site mutations that disrupt normal protein production
  • Pathogenic variants associated with sideroblastic anemia
  • Genetic markers linked to ataxia development

The test utilizes next-generation sequencing technology to examine the entire coding region of the ABCB7 gene, ensuring maximum detection sensitivity for both known and novel mutations. This comprehensive approach provides clinicians with the detailed genetic information needed to confirm diagnosis and guide treatment decisions.

Who Should Consider This Genetic Test

This specialized genetic test is recommended for individuals experiencing:

  • Unexplained anemia that doesn’t respond to conventional iron therapy
  • Family history of sideroblastic anemia or neurological disorders
  • Progressive coordination difficulties and balance problems
  • Developmental delays in childhood with hematological abnormalities
  • Ringed sideroblasts visible in bone marrow examinations
  • Elevated iron levels despite anemia symptoms
  • Neurological symptoms including tremors, speech difficulties, or gait abnormalities

Key Benefits of ABCB7 Genetic Testing

Undergoing the ABCB7 Gene Anemia Sideroblastic with Ataxia NGS Genetic DNA Test offers numerous advantages:

  • Accurate Diagnosis: Provides definitive confirmation of ABCB7-related disorders, eliminating diagnostic uncertainty
  • Personalized Treatment: Enables targeted therapeutic approaches based on specific genetic findings
  • Family Planning: Offers crucial information for genetic counseling and reproductive decision-making
  • Early Intervention: Facilitates timely management strategies to prevent complications
  • Comprehensive Care: Supports coordinated care between hematologists and neurologists
  • Prognostic Information: Helps predict disease progression and potential complications

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of certified genetic counselors and hematology specialists:

  • Positive Result: Indicates the presence of pathogenic ABCB7 gene mutations, confirming the diagnosis of sideroblastic anemia with ataxia
  • Negative Result: Suggests that ABCB7 gene mutations are not the cause of your symptoms, guiding further diagnostic evaluation
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires additional investigation
  • Carrier Status: Determines if you carry a single copy of a mutated gene, important for family planning considerations

All results include detailed explanations and recommendations for next steps, ensuring you have the information needed to make informed healthcare decisions with your medical team.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3-4 Weeks
Sample Type Blood

Nationwide Testing Availability

We proudly offer the ABCB7 Gene Anemia Sideroblastic with Ataxia NGS Genetic DNA Test at our state-of-the-art facilities across the United States. Our network includes specialized testing centers in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Each location maintains the same high standards of genetic testing excellence and patient care.

Take the Next Step Toward Diagnosis

If you or a family member are experiencing symptoms suggestive of ABCB7-related disorders, don’t wait to get answers. Our comprehensive genetic testing provides the clarity needed for proper diagnosis and treatment planning. Contact our genetic counseling team today to schedule your test and begin your journey toward better health management.

Call or WhatsApp us at +1(267) 388-9828 to book your ABCB7 Gene Anemia Sideroblastic with Ataxia NGS Genetic DNA Test today. Our knowledgeable staff is ready to answer your questions and help you schedule your appointment at a location convenient for you.